This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Remington, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Remington, J. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2000, p. 3967-3970, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Detection of Immunoglobulin M Antibodies to P35 Antigen of Toxoplasma gondii for Serodiagnosis of Recently Acquired Infection in Pregnant Women

Yasuhiro Suzuki,1,2,* Raymund Ramirez,1 Cindy Press,1 Shuli Li,1,2 Stephen Parmley,1,dagger Philippe Thulliez,3 and Jack S. Remington1,2

Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 943011; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 943052; and Laboratoire de Serologie Neonatale et de Recherche sur la Toxoplasmose, Institut de Puericulture de Paris, 75014 Paris, France3

Received 8 June 2000/Returned for modification 17 July 2000/Accepted 18 August 2000

We examined the efficiency of detection of immunoglobulin M (IgM) antibodies to a 35-kDa antigen (P35) of Toxoplasma gondii for serodiagnosis of acute infection in pregnant women. A double-sandwich enzyme-linked immunosorbent assay (ELISA) with recombinant P35 antigen (P35-IgM-ELISA) was used for this purpose. On the basis of the clinical history and the combination of results from the toxoplasma serological profile (Sabin-Feldman dye test, conventional IgM and IgA ELISAs, and the differential agglutination test), the patients were classified into three groups: group I, status suggestive of recently acquired infection; group II, status suggestive of infection acquired in the distant past; group III, status suggestive of persisting IgM antibodies. Eighteen (90.0%) of 20 serum samples from group I patients were positive by the P35-IgM-ELISA, whereas none of the 33 serum samples from group II patients were positive. Only 4 (25.0%) of 16 serum samples from group III patients were positive by the P35-IgM-ELISA, whereas all these serum samples were positive by the conventional IgM ELISA. These results indicate that demonstration of IgM antibodies against P35 by the P35-IgM-ELISA is more specific for the acute stage of the infection than demonstration of IgM antibodies by the ELISA that uses a whole-lysate antigen preparation. Studies with sera obtained from four pregnant women who seroconverted (IgG and IgM antibodies) during pregnancy revealed that two of them became negative by the P35-IgM-ELISA between 4 and 6 months after seroconversion, whereas the conventional IgM ELISA titers remained highly positive. The P35-IgM-ELISA appears to be useful for differentiating recently acquired infection from those acquired in the distant past in pregnant women.

* Corresponding author. Mailing address: Research Institute, Palo Alto Medical Foundation, 795 El Camino Real, Ames Building, Palo Alto, CA 94301. Phone: (650) 326-8120. Fax: (650) 329-9853. E-mail: ysuzuki{at}leland.stanford.edu.

dagger Present address: Maxygen, Redwood City, CA 94063.

Journal of Clinical Microbiology, November 2000, p. 3967-3970, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Beghetto, E., Spadoni, A., Bruno, L., Buffolano, W., Gargano, N. (2006). Chimeric Antigens of Toxoplasma gondii: Toward Standardization of Toxoplasmosis Serodiagnosis Using Recombinant Products.. J. Clin. Microbiol. 44: 2133-2140 [Abstract] [Full Text]  
  • Buffolano, W., Beghetto, E., Del Pezzo, M., Spadoni, A., Di Cristina, M., Petersen, E., Gargano, N. (2005). Use of Recombinant Antigens for Early Postnatal Diagnosis of Congenital Toxoplasmosis. J. Clin. Microbiol. 43: 5916-5924 [Abstract] [Full Text]  
  • Zhou, X. W., Kafsack, B. F. C., Cole, R. N., Beckett, P., Shen, R. F., Carruthers, V. B. (2005). The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse Legion of Invasion and Survival Proteins. J. Biol. Chem. 280: 34233-34244 [Abstract] [Full Text]  
  • Pfrepper, K.-I., Enders, G., Gohl, M., Krczal, D., Hlobil, H., Wassenberg, D., Soutschek, E. (2005). Seroreactivity to and Avidity for Recombinant Antigens in Toxoplasmosis. CVI 12: 977-982 [Abstract] [Full Text]  
  • Ferrandiz, J., Mercier, C., Wallon, M., Picot, S., Cesbron-Delauw, M.-F., Peyron, F. (2004). Limited Value of Assays Using Detection of Immunoglobulin G Antibodies to the Two Recombinant Dense Granule Antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for Distinguishing between Acute and Chronic Infections in Pregnant Women. CVI 11: 1016-1021 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»